Forte Biosciences
FBRX
30 hedge funds and large institutions have $11.1M invested in Forte Biosciences in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 8 closing their positions.
10,900% more call options, than puts
Call options by funds: $110K | Put options by funds: $1K
207% more capital invested
Capital invested by funds: $3.6M → $11.1M (+$7.45M)
1.18% more ownership
Funds ownership: 0.66% → 1.84% (+1.2%)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
3% less funds holding
Funds holding: 31 → 30 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tybourne Capital Management
Hong Kong
|
+$3.21M |
| 2 |
PA
Perceptive Advisors
New York
|
+$2.9M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$2.64M |
| 4 |
FAM
Fred Alger Management
New York
|
+$1.63M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$1.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OWP
Old Well Partners
Charlotte,
North Carolina
|
-$71.3K |
| 2 |
Renaissance Technologies
New York
|
-$69.1K |
| 3 |
Millennium Management
New York
|
-$59.4K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$38.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Russell Investments Group
London,
United Kingdom
| $299 | – | – | – |
|
27
Wells Fargo
San Francisco,
California
| $156 | +$66 | +3 | +50% |
|
|
LWCFA
28
Loring Wolcott & Coolidge Fiduciary Advisors
Boston,
Massachusetts
| $92 | – | – | – |
|
29
JP Morgan Chase
New York
| $11 | – | – | – |
|
30
Qube Research & Technologies (QRT)
London,
United Kingdom
| $2 | – | – | – |
|
|
OWP
31
Old Well Partners
Charlotte,
North Carolina
| – | -$71.3K | -2,744 | Closed |
|
|
32
Millennium Management
New York
| – | -$59.4K | -2,284 | Closed |
|
|
BCM
33
Bridgeway Capital Management
Houston,
Texas
| – | -$38.3K | -1,475 | Closed |
|
|
34
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$31.5K | -1,213 | Closed |
|
35
Citadel Advisors
Miami,
Florida
| – | -$19.9K | -900 | Closed |
|
|
FIA
36
FNY Investment Advisers
New York
| – | -$9K | -383 | Closed |
|
37
Simplex Trading
Chicago,
Illinois
| – | -$1.2K | -54 | Closed |
|
FBRX Hedge Fund Activity: Q3 2023 in Review
30 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q3 2023, worth a combined $11.1M — up 207% from $3.6M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of FBRX and 7 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 6 added.
The largest buyer was Tybourne Capital Management, opening a new position worth an estimated $3.21M. The largest seller was Old Well Partners, exiting entirely with an estimated $71.3K sold.
- 30 institutional investors held Forte Biosciences (FBRX) as of Q3 2023, down from 31 in Q2 2023.
- Funds reported $11.1M of Forte Biosciences stock for Q3 2023, up 207% quarter-over-quarter.
- 7 funds opened new Forte Biosciences positions in Q3 2023 and 8 closed out, a net change of -1 holder.
- The largest Forte Biosciences buyer in Q3 2023 was Tybourne Capital Management, an estimated $3.21M added.
- The largest Forte Biosciences seller in Q3 2023 was Old Well Partners, an estimated $71.3K sold.
Based on aggregated 13F filings for Q3 2023.